BioCentury
ARTICLE | Clinical News

Lenvima lenvatinib: Additional Phase II data

June 8, 2015 7:00 AM UTC

Additional data from the Phase II portion of the open-label, international Phase Ib/II Study 205 in 153 patients with unresectable, advanced or metastatic RCC following 1 prior VEGF-targeted treatment...